Patents by Inventor Revital Nimri

Revital Nimri has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210193285
    Abstract: Aspects of embodiments pertain to a method for use in disease treatment management comprising: receiving data indicative of pump treatment parameters; analyzing physiological data during use of a pump; said physiological data being indicative of a physiological characteristic of the patient; analyzing the received pump treatment parameters data to thereby identify at least one patient-related treatment characteristic; creating data indicative of multiple daily injections (MDI) treatment parameters by automatically determining individualized insulin dosing injection parameters data based on said at least one patient-related treatment characteristic and said physiological data.
    Type: Application
    Filed: October 16, 2018
    Publication date: June 24, 2021
    Inventors: Revital Nimri, Moshe Phillip, Eran Atlas, Ido Muller, Ilana Klovatch, Eran Agmon
  • Publication number: 20200060624
    Abstract: The present invention discloses a monitoring system and method for use in monitoring diabetes treatment of a patient. The system comprises a control unit comprising a first processor module for processing measured data indicative of blood glucose level and generating first processed data indicative thereof, a second processor module comprising at least one fuzzy logic module; the second processor module receives input parameters corresponding to the measured data, the first processed data and a reference data including individualized patient's profile related data, individualized patient's treatment history related data and processes the received data to produce at least one qualitative output parameter indicative of patient's treatment parameters, such that the second processor module determines whether any of the treatment parameters is to be modified.
    Type: Application
    Filed: October 30, 2019
    Publication date: February 27, 2020
    Inventors: Eran Atlas, Revital Nimri, Shahar Miller, Eli Aviram Grunberg, Moshe Phillip
  • Patent number: 9507917
    Abstract: Monitoring system and method for use with diabetic treatment management. The system comprises: a communication interface configured to permit access to stored raw log data, obtained over a certain time, being indicative of glucose measurements, meals consumed and insulin delivery; and a control unit comprising an unsupervised learning controller configured to receive and process said raw log data and determine at least one global insulin pump setting of basal rate, correction factor, carbohydrate ratio and insulin activity curve parameters. The system may comprise a processing unit comprising a first processor for processing measured data indicative of blood glucose level and generating first processed data, a second processor comprising at least one fuzzy logic module which receives input parameters corresponding to the measured data, the first processed data and a reference data, and processes the data to produce a qualitative output parameter to determine whether any treatment parameter should be modified.
    Type: Grant
    Filed: January 21, 2015
    Date of Patent: November 29, 2016
    Assignee: DreaMed Diabetes Ltd.
    Inventors: Eran Atlas, Revital Nimri, Shahar Miller, Eli Aviram Grunberg, Moshe Phillip
  • Publication number: 20150134356
    Abstract: Monitoring system and method for use with diabetic treatment management. The system comprises: a communication interface configured to permit access to stored raw log data, obtained over a certain time, being indicative of glucose measurements, meals consumed and insulin delivery; and a control unit comprising an unsupervised learning controller configured to receive and process said raw log data and determine at least one global insulin pump setting of basal rate, correction factor, carbohydrate ratio and insulin activity curve parameters. The system may comprise a processing unit comprising a first processor for processing measured data indicative of blood glucose level and generating first processed data, a second processor comprising at least one fuzzy logic module which receives input parameters corresponding to the measured data, the first processed data and a reference data, and processes the data to produce a qualitative output parameter to determine whether any treatment parameter should be modified.
    Type: Application
    Filed: January 21, 2015
    Publication date: May 14, 2015
    Inventors: Eran Atlas, Revital Nimri, Shahar Miller, Eli Aviram Grunberg, Moshe Phillip
  • Patent number: 8954373
    Abstract: Monitoring system and method for use with diabetic treatment management. The system includes: a communication interface configured to permit access to stored raw log data, obtained over a certain time, being indicative of glucose measurements, meals consumed and insulin delivery; and a control unit including an unsupervised learning controller configured to receive and process said raw log data and determine at least one global insulin pump setting of basal rate, correction factor, carbohydrate ratio and insulin activity curve parameters. The system may include a processing unit including a first processor for processing measured data indicative of blood glucose level and generating first processed data, a second processor including at least one fuzzy logic module which receives input parameters corresponding to the measured data, the first processed data and a reference data, and processes the data to produce a qualitative output parameter to determine whether any treatment parameter should be modified.
    Type: Grant
    Filed: March 29, 2012
    Date of Patent: February 10, 2015
    Assignee: DreaMed Diabetes Ltd.
    Inventors: Eran Atlas, Revital Nimri, Shahar Miller, Eli Aviram Grunberg, Moshe Phillip
  • Publication number: 20120246106
    Abstract: Monitoring system and method for use with diabetic treatment management. The system includes: a communication interface configured to permit access to stored raw log data, obtained over a certain time, being indicative of glucose measurements, meals consumed and insulin delivery; and a control unit including an unsupervised learning controller configured to receive and process said raw log data and determine at least one global insulin pump setting of basal rate, correction factor, carbohydrate ratio and insulin activity curve parameters. The system may include a processing unit including a first processor for processing measured data indicative of blood glucose level and generating first processed data, a second processor including at least one fuzzy logic module which receives input parameters corresponding to the measured data, the first processed data and a reference data, and processes the data to produce a qualitative output parameter to determine whether any treatment parameter should be modified.
    Type: Application
    Filed: March 29, 2012
    Publication date: September 27, 2012
    Applicant: MOR RESEARCH APPLICATIONS LTD.
    Inventors: Eran ATLAS, Revital NIMRI, Shahar MILLER, Eli Aviram GRUNBERG, Moshe PHILLIP
  • Publication number: 20120123234
    Abstract: The present invention discloses a monitoring system and method for use in monitoring diabetes treatment of a patient. The system comprises a control unit comprising a first processor module for processing measured data indicative of blood glucose level and generating first processed data indicative thereof, a second processor module comprising at least one fuzzy logic module; the second processor module receives input parameters corresponding to the measured data, the first processed data and a reference data including individualized patient's profile related data, to individualized patient's treatment history related data and processes the received data to produce at least one qualitative output parameter indicative of patient's treatment parameters, such that the second processor module determines whether any of the treatment parameters is to be modified.
    Type: Application
    Filed: February 25, 2010
    Publication date: May 17, 2012
    Inventors: Eran Atlas, Revital Nimri, Shahar Miller, Eli Aviram Grunberg, Moshe Phillip